Biodegradable sirolimus-loaded poly(lactide) nanoparticles as delivery systems for the prevention of restenosis in coronary stent application

IFMBE Proceedings

Volumn 25, Issue 10, 2009, Pages 193-196

  Luderer, F ^a   Sternberg, K ^a   Rohm, H W ^a   Lobler M ^a   Kock K ^b   Kroemer, H K ^b   Schmitz, K P ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Biodegradable; Nanoparticle; Poly(lactide); Restenosis; Sirolimus

Indexed keywords

ARTIFICIAL ORGANS; BIOCOMPATIBILITY; CELL CULTURE; CONTROLLED DRUG DELIVERY; DISEASES; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MEDICAL PHYSICS; SCANNING ELECTRON MICROSCOPY; STENTS; TARGETED DRUG DELIVERY; TISSUE; TISSUE ENGINEERING;

BIODEGRADABLE; CONFOCAL LASER SCANNING MICROSCOPY; CORONARY STENTS; DELIVERY SYSTEMS; IN-STENT RESTENOSIS; POLY LACTIDE; RESTENOSIS; SIROLIMUS;

NANOPARTICLES;

EID: 77950144571     PISSN: 16800737     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1007/978-3-642-03900-3_56     Document Type: Conference Paper

References (4)

1. Feyter de PJ, Vos J, Rensing BJ (2000) Anti-restenosis Trials.Curr Interv Cardiol Rev 2 (4):326-331
2. Wilensky RL, March KL, Hathaway DR (1991) Direct intraarterial wall injection of microparticles via a catheter: a potential drug delivery strategy following angioplasty. Am Heart J 122:1136-1140
3. Torchilin VP (2006) Nanoparticulates as Drug Carriers. Imperial College Press, London
4. Stolnik S, Davies MC, Illum L, Davis SS, et al. (1994) The preparation of sub 200 nm biodegradable colloidal particles. Modification of Poly(lactide-co-glycolide). J Control Rel (30): 57-67